c-Met and Its Ligand Hepatocyte Growth Factor/Scatter Factor Regulate Mature B Cell Survival in a Pathway Induced by CD74

The signals regulating the survival of mature splenic B cells have become a major focus in recent studies of B cell immunology. Durable B cell persistence in the periphery is dependent on survival signals that are transduced by cell surface receptors. In this study, we describe a novel biological mechanism involved in mature B cell homeostasis, the hepatocyte growth factor/scatter factor (HGF)/c-Met pathway. We demonstrate that c-Met activation by HGF leads to a survival cascade, whereas its blockade results in induction of mature B cell death. Our results emphasize a unique and critical function for c-Met signaling in the previously described macrophage migration inhibitory factor/CD74-induced survival pathway. Macrophage migration inhibitory factor recruits c-Met to the CD74/CD44 complex and thereby enables the induction of a signaling cascade within the cell. This signal results in HGF secretion, which stimulates the survival of the mature B cell population in an autocrine manner. Thus, the CD74–HGF/c-Met axis defines a novel physiologic survival pathway in mature B cells, resulting in the control of the humoral immune response.

[1]  R. Geahlen.  Syk and pTyr'd: Signaling through the B cell antigen receptor. , 2009, Biochimica et biophysica acta.

[2]  A. Sharabi,et al.  B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus. , 2009, Clinical immunology.

[3]  Steffen Jung,et al.  Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches , 2008, Nature Immunology.

[4]  S. Giordano,et al.  Molecular cancer therapy: can our expectation be MET? , 2008, European journal of cancer.

[5]  B. Foveau,et al.  The shadow of death on the MET tyrosine kinase receptor , 2008, Cell Death and Differentiation.

[6]  L. Leng,et al.  Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex* , 2008, Journal of Biological Chemistry.

[7]  L. Trusolino,et al.  The Met tyrosine kinase receptor in development and cancer , 2008, Cancer and Metastasis Reviews.

[8]  L. Leng,et al.  CD74 induces TAp63 expression leading to B-cell survival. , 2007, Blood.

[9]  A. Berrebi,et al.  IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival , 2007, Proceedings of the National Academy of Sciences.

[10]  P. Herrlich,et al.  Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. , 2006, Molecular biology of the cell.

[11]  L. Leng,et al.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.

[12]  R. Woodland,et al.  BLyS and B cell homeostasis. , 2006, Seminars in immunology.

[13]  A. Berrebi,et al.  Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. , 2006, Blood.

[14]  R. Bende,et al.  Follicular Dendritic Cells Catalyze Hepatocyte Growth Factor (HGF) Activation in the Germinal Center Microenvironment by Secreting the Serine Protease HGF Activator , 2005, The Journal of Immunology.

[15]  M. Cancro,et al.  Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands. , 2005, Seminars in immunology.

[16]  P. Comoglio,et al.  Cancer therapy: can the challenge be MET? , 2005, Trends in molecular medicine.

[17]  Ravi Salgia,et al.  Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. , 2005, Cancer research.

[18]  D. Goldenberg,et al.  Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. , 2004, Blood.

[19]  H. Zinger,et al.  A Peptide Based on the Complementarity Determining Region 1 of a Human Monoclonal Autoantibody Ameliorates Spontaneous and Induced Lupus Manifestations in Correlation with Cytokine Immunomodulation , 2004, Journal of Clinical Immunology.

[20]  K. Meyer-Siegler,et al.  Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells , 2004, BMC Cancer.

[21]  N. Rajewsky,et al.  Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer , 2004, Cell.

[22]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[23]  Y. Yoo,et al.  Orphan Nuclear Receptor Nur77 Translocates to Mitochondria in the Early Phase of Apoptosis Induced by Synthetic Chenodeoxycholic Acid Derivatives in Human Stomach Cancer Cell Line SNU‐1 , 2003, Annals of the New York Academy of Sciences.

[24]  A. Bertotti,et al.  Tyrosine kinase signal specificity: lessons from the HGF receptor. , 2003, Trends in biochemical sciences.

[25]  T. Calandra,et al.  Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. , 2003, The Journal of infectious diseases.

[26]  L. Leng,et al.  MIF Signal Transduction Initiated by Binding to CD74 , 2003, The Journal of experimental medicine.

[27]  Jin-Hwang Liu,et al.  High serum hepatocyte growth factor level in patients with non‐Hodgkin's lymphoma , 2003, European journal of haematology.

[28]  I. Shachar,et al.  Invariant chain, a chain of command. , 2003, Trends in immunology.

[29]  R. Bende,et al.  The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma , 2003, Leukemia.

[30]  G. V. Vande Woude,et al.  HGF/SF‐met signaling in the control of branching morphogenesis and invasion , 2003, Journal of cellular biochemistry.

[31]  J. Sleeman,et al.  CD44 is required for two consecutive steps in HGF/c-Met signaling. , 2002, Genes & development.

[32]  I. Shachar,et al.  Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain. , 2002, Immunity.

[33]  S. Becker-Herman,et al.  Id2 Negatively Regulates B Cell Differentiation in the Spleen1 , 2002, The Journal of Immunology.

[34]  E. Puré,et al.  Resolution of Lung Inflammation by CD44 , 2002, Science.

[35]  N. Funata,et al.  Expression of Macrophage Migration Inhibitory Factor in Human Breast Cancer: Association with Nodal Spread , 2002, Japanese journal of cancer research : Gann.

[36]  D. Rawlings,et al.  Transitional B Lymphocyte Subsets Operate as Distinct Checkpoints in Murine Splenic B Cell Development1 , 2002, The Journal of Immunology.

[37]  M. V. van Oers,et al.  Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. , 2002, Blood.

[38]  P. Benaroch,et al.  Multiple roles of the invariant chain in MHC class II function. , 2002, Biochimica et biophysica acta.

[39]  H. Nakauchi,et al.  Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver , 2002, The Journal of cell biology.

[40]  J. Tschopp,et al.  Maturation of Marginal Zone and Follicular B Cells Requires B Cell Activating Factor of the Tumor Necrosis Factor Family and Is Independent of B Cell Maturation Antigen , 2001, The Journal of experimental medicine.

[41]  M. Scott,et al.  An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway , 2001, Science.

[42]  R. Dikstein,et al.  Invariant Chain Induces B Cell Maturation by Activating a TAFII105-NF-κB-dependent Transcription Program* , 2001, The Journal of Biological Chemistry.

[43]  S. Natsugoe,et al.  Invariant chain expression in gastric cancer. , 2001, Cancer letters.

[44]  F. Marshall,et al.  Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. , 2001, The American journal of pathology.

[45]  S. Pileri,et al.  Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. , 2001, Blood.

[46]  G. Freeman,et al.  Expression of MHC Class II-Associated Invariant Chain (Ii;CD74) in Thymic Epithelial Neoplasms , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[47]  J. Tschopp,et al.  Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population , 2000, The Journal of experimental medicine.

[48]  J. Nishihira,et al.  Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. , 2000, International journal of molecular medicine.

[49]  P. Sideras,et al.  B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor–Derived Signals , 1999, The Journal of experimental medicine.

[50]  E. Gherardi,et al.  Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met* , 1999, The Journal of Biological Chemistry.

[51]  R. Bucala,et al.  An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma , 1999, Molecular medicine.

[52]  C. Birchmeier,et al.  Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.

[53]  S. Ikehara,et al.  Stimulatory Effects of Hepatocyte Growth Factor on Hemopoiesis of SCF/c‐kit System‐Deficient Mice , 1998, Stem cells.

[54]  P. A. van der Ley,et al.  Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine , 1997, Infection and immunity.

[55]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[56]  D. de Jong,et al.  Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins , 1997 .

[57]  Yuji Sato,et al.  Macrophage Migration Inhibitory Factor (MIF) , 1996 .

[58]  A. Waage,et al.  Hepatocyte growth factor and its receptor c-met in multiple myeloma. , 1996, Blood.

[59]  R. Flavell,et al.  Requirement for Invariant Chain in B Cell Maturation and Function , 1996, Science.

[60]  K. Meyer-Siegler,et al.  Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. , 1996, Urology.

[61]  J. Bishop,et al.  Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Burger,et al.  Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization. , 1995, Oncogene.

[63]  Carmen Birchmeier,et al.  Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud , 1995, Nature.

[64]  S. Ikehara,et al.  Hepatocyte growth factor as a hematopoietic regulator. , 1995, Blood.

[65]  M. Sharpe,et al.  Scatter factor/hepatocyte growth factor is essential for liver development , 1995, Nature.

[66]  Tetsuo Noda,et al.  Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor , 1995, Nature.

[67]  J. Bernhagen,et al.  Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.

[68]  I. Mellman,et al.  The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules , 1994, The Journal of experimental medicine.

[69]  Mark S. Anderson,et al.  The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.

[70]  G. V. Vande Woude,et al.  Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[71]  C. Cooper,et al.  Tyrosine kinase receptor indistinguishable from the c-met protein , 1989, Nature.

[72]  N. Rajewsky,et al.  Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. , 2004, Cell.

[73]  Yuji Sato,et al.  Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. , 2003, Annals of the New York Academy of Sciences.

[74]  R. Dikstein,et al.  Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program. , 2001, The Journal of biological chemistry.

[75]  D. de Jong,et al.  Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. , 1997, Blood.

[76]  S. Pambuccian,et al.  Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications. , 1996, The American journal of surgical pathology.

[77]  S. Strom,et al.  Hepatocyte growth factor enhances B-cell activity. , 1993, Life sciences.